NO20031402L - Analyser for identifisering av reseptorer som har endringer i signalisering - Google Patents

Analyser for identifisering av reseptorer som har endringer i signalisering

Info

Publication number
NO20031402L
NO20031402L NO20031402A NO20031402A NO20031402L NO 20031402 L NO20031402 L NO 20031402L NO 20031402 A NO20031402 A NO 20031402A NO 20031402 A NO20031402 A NO 20031402A NO 20031402 L NO20031402 L NO 20031402L
Authority
NO
Norway
Prior art keywords
receptors
assays
signaling
identification
changes
Prior art date
Application number
NO20031402A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031402D0 (no
Inventor
Alan S Kopin
Martin Beinborn
Original Assignee
New England Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Medical Center Inc filed Critical New England Medical Center Inc
Publication of NO20031402D0 publication Critical patent/NO20031402D0/no
Publication of NO20031402L publication Critical patent/NO20031402L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4719—G-proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrane Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
NO20031402A 2000-09-28 2003-03-27 Analyser for identifisering av reseptorer som har endringer i signalisering NO20031402L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23630200P 2000-09-28 2000-09-28
US28864401P 2001-05-03 2001-05-03
PCT/US2001/042416 WO2002027015A2 (fr) 2000-09-28 2001-09-28 Dosages d'identifications de recepteurs presentant des alterations de signaux de transduction

Publications (2)

Publication Number Publication Date
NO20031402D0 NO20031402D0 (no) 2003-03-27
NO20031402L true NO20031402L (no) 2003-05-26

Family

ID=26929652

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031402A NO20031402L (no) 2000-09-28 2003-03-27 Analyser for identifisering av reseptorer som har endringer i signalisering

Country Status (12)

Country Link
US (1) US20020127539A1 (fr)
EP (1) EP1328663A4 (fr)
JP (1) JP2004526415A (fr)
KR (1) KR20030048414A (fr)
AU (1) AU2001296953A1 (fr)
BR (1) BR0114382A (fr)
CA (1) CA2421933A1 (fr)
IL (1) IL154902A0 (fr)
MX (1) MXPA03002812A (fr)
NO (1) NO20031402L (fr)
NZ (1) NZ524854A (fr)
WO (1) WO2002027015A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113612899A (zh) * 2021-07-26 2021-11-05 中国矿业大学 基于rna和像素深度的图像加密方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
DE4138621A1 (de) * 1991-11-25 1993-06-17 Boehringer Ingelheim Int Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabhaengigen zellulaeren signaluebertragungsweg
US6255059B1 (en) * 1993-03-31 2001-07-03 Cadus Pharmaceutical Corporation Methods for identifying G protein coupled receptor effectors
WO1998016557A1 (fr) * 1996-10-11 1998-04-23 The General Hospital Corporation Dosages pour recepteurs lies a la proteine g
AU6343998A (en) * 1997-02-27 1998-09-18 Christina C. Egan Constitutively activated serotonin receptors

Also Published As

Publication number Publication date
NO20031402D0 (no) 2003-03-27
BR0114382A (pt) 2003-09-30
EP1328663A2 (fr) 2003-07-23
AU2001296953A1 (en) 2002-04-08
MXPA03002812A (es) 2005-02-25
KR20030048414A (ko) 2003-06-19
IL154902A0 (en) 2003-10-31
JP2004526415A (ja) 2004-09-02
CA2421933A1 (fr) 2002-04-04
EP1328663A4 (fr) 2005-06-01
US20020127539A1 (en) 2002-09-12
WO2002027015A3 (fr) 2002-09-12
WO2002027015A2 (fr) 2002-04-04
NZ524854A (en) 2004-02-27

Similar Documents

Publication Publication Date Title
NO20023663L (no) Broplugg
NO20043564L (no) Follistatindomene som inneholder proteiner
DK1492786T3 (da) Pyridinoylpiperidiner som 5-HT1F-agonister
DE60321162D1 (de) Text-zu-sprache für handgeräte
DE60336262D1 (de) Herstellungsverfahren für polyolefin-nanocomposites
NO20041887L (no) Benzomidazoler anvendelige som proteinkinase-inhibitorer
NO20033593L (no) Kinazoliner som MMP-13 inhibitorer
DK1527035T3 (da) Kontinuerlig fremgangsmåde til alkyleringen af carbonhydrider
NO20032382L (no) LFA-1-antagonistforbindelser
DE60227987D1 (de) Drainagevorrichtung für den harnleiter
DE60235536D1 (de) Sulfonamidderivate
NO20034949D0 (no) Sulfonamider
DE60234205D1 (de) Abgabevorrichtung für flüssigkeiten
NO20016259D0 (no) Trosse
DE50206910D1 (de) Substituierte y-lactonverbindungen als nmda-antagonisten
DE10196444T1 (de) Prüfvorrichtung
NO20031402D0 (no) Analyser for identifisering av reseptorer som har endringer i signalisering
DE50109815D1 (de) Querschwelle für eisenbahngleise
DE60133014D1 (de) H3 agonisten oder antagonisten
NO20025459D0 (no) Sulfonamidderivater
FI20010896A (fi) Linjatestausjärjestely
DE60009399D1 (de) Signaleinrichtung, insbesondere für Strassen
DE60135471D1 (de) H3 agonisten oder antagonisten
DE60305410D1 (de) Flasche für Flüssigkeiten
NO20040318L (no) Loftesystem for fergelandgangsbrygge.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application